Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Gilead Sciences Inc (GILD)

81.63 +1.62 (+2.02%)

10/19/2017  3:50pm

Open:

81.53

Pre. Close:

80.01

High:

82.47

Low:

80.51

Volume:

12,585,636

Market Cap:

106.60B

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

81.22 - 81.74

81.74 - 82.19

Low:

78.01 - 78.7

78.7 - 79.3

Close:

78.83 - 79.92

79.92 - 80.87

Technical analysis  (as of: 2017-10-19 3:26:00 PM)

Overall:

      

Stoxline posted a STRONG BUY today, upgraded from lower rating. This stock seems to be very strong for long buyers. If you bought, continue to hold stock until SELL signal. You are relatively safe as long as the SELL warning is not issued.

Target:

Six months: 96.50     One year: 98.96

Support:

Support1: 79.21    Support2: 65.90

Resistance:

Resistance1: 82.62    Resistance2: 84.73

Pivot:

81.84

Moving Averages:

MA(5): 80.58     MA(20): 82.15

MA(100): 75.01     MA(250): 72.31

MACD:

MACD(12,26): -0.04     Signal(12,26,9): 0.37

%K %D:

%K(14,3): 26.92     %D(3): 21.96

RSI:

RSI(14): 50.68

52-Week:

High: 86.27  Low: 63.76  Change(%): 9.8

Average Vol(K):

3-Month: 874431  10-Days 294135

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
GILD has closed above bottom band by 43.8%. Bollinger Bands are 26.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 18 Oct 2017 15:45:00 GMT
The Math Behind the Gilead's Recent Merger

Thu, 19 Oct 2017 06:11:15 GMT
FDA Approval Of Gilead CAR-T Therapy Will Move The Needle

Thu, 19 Oct 2017 14:37:30 GMT
Lynch & Associates Buys DowDuPont Inc, Gilead Sciences Inc, Cisco Systems Inc ...

Mon, 02 Oct 2017 12:56:15 GMT
Better Buy: Gilead Sciences, Inc. vs. Pfizer

Thu, 19 Oct 2017 13:05:27 GMT
Gilead Sciences Poised to Make a Push Toward $100?

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

Shares Float (M)

1297.79

% Held by Insiders

0.69

% Held by Institutions

77.44

Shares Short (K)

16840

Shares Short Prior Month (K)

13380

Stock Financials

EPS

9.210

EPS Est. Current Year

8.750

EPS Est. Next Year

7.440

EPS Est. Next Quarter

1.930

Forward EPS

7.488

Book Value (p.s.)

17.360

PEG Ratio

-1.13

Profit Margin

42.90

Operating Margin

58.96

Return on Assets (ttm)

19.0

Return on Equity (ttm)

62.2

Qtrly Rev. Growth

-8.2

Gross Profit (p.s.)

19.947

Sales Per Share

EBITDA (p.s.)

13.718

Qtrly Earnings Growth

-12.10

Operating Cash Flow (M)

14010.00

Levered Free Cash Flow (M)

12170.00

FoxReading.com

Valuation

P/E

8.85

P/E Growth Ratio

0.02

P/BV

4.70

P/S

4927648256.00

P/CF

Dividend Yield

0.03

Dividends & Splits

Dividend

2.080

Dividend Pay Date

2017-06-29

Ex-Dividend Date

2017-09-14

Forward Dividend

2.080

Last Split Date

2013-01-28

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.